Ido Weinberg, MD Profile
Ido Weinberg, MD

@Angiologist

Followers
5K
Following
4K
Media
2K
Statuses
9K

Vascular MD @MassGeneralNews. https://t.co/5UlkMMW7Fd. @SVM_tweets. https://t.co/pVr7r1hs6L. https://t.co/cLUO9bvIOd. The Machine will be God.

Boston
Joined January 2011
Don't wanna be here? Send us removal request.
@VMJ_SVM
VascularMedicine
2 years
From the current issue: Primary results of the SAVAL randomized trial. https://t.co/Vm0CQ9JFcX #CLTI #PeripheralArteryDisease #VascularTwitter
1
66
26
@VMJ_SVM
VascularMedicine
2 years
Online First! @GiacomoBuso and colleagues share humbling data suggesting high rates of symptomatic vascular events in patients with vascular Ehlers-Danlos syndrome despite celiprolol therapy. #VEDS #VEDSAwarenss
2
63
22
@Angiologist
Ido Weinberg, MD
2 years
Subclavian artery stenosis - Most patients are asymptomatic. Medical therapy is key. Procedures are for symptoms. Learn more here: https://t.co/yHn3gmcPgs @MGHVascular @GParmar_MD @DougDrachmanMD @MGHHeartHealth
1
69
25
@SVM_tweets
Society for Vascular Medicine | SVM
2 years
Did you know there is ~25% added #mortality in patients with #PAD compared to those who don’t? Join the discussion w/ @GParmar_MD @MGHVascular to learn more about PAD & mortality benefits of low #LDL https://t.co/0meskVGZT0 @PVDCouncil @lipiddoc @nationallipid @lipid @hmpVDM
1
61
24
@Angiologist
Ido Weinberg, MD
2 years
Avoid this MISTAKE in BLOOD PRESSURE measurement*,** https://t.co/X7miK1plfD *Ok. I hate clickbait too. Measure BP in BOTH arms. But still, watch the short clip, LIKE, SHARE, SUBSCRIBE. **Yup. That's my BP, HR and hair... @EricSecemskyMD @GParmar_MD @VladLakhter @SVM_tweets
0
66
28
@SVM_tweets
Society for Vascular Medicine | SVM
2 years
It’s not just “go home & walk” Home based walking exercise does work if done right. Coaching & connecting with patients is also crucial. It was incredible to have Dr McDermott & @CardioNeela , the lead authors of the article, join the discussion! @AlexVakiliMD @emoryheart #SVM
2
79
30
@Angiologist
Ido Weinberg, MD
2 years
I often don't know what to do with high-sensitivity troponin. Congratulations @bbikdeli et al. for helping confirm our suspicion that we should take it with a grain of salt... https://t.co/nIsa7m1NVW @PERTConsortium @GParmar_MD @AndrewDicksMD maybe a @SVM_tweets JC paper? ;)
1
73
50
@SVM_tweets
Society for Vascular Medicine | SVM
2 years
Are you interested in #Cardiology #VascularSurgery #VascularMedicine #IR ? Don’t miss this amazing learning opportunity for #residents #fellows #APPs ! Registration is now OPEN! Join #SVM & register today https://t.co/SqgoC4MlQt @heatherlgornik @adityasharmamd @RKolluriMD
2
80
55
@SVM_tweets
Society for Vascular Medicine | SVM
2 years
In case you missed it! #GivingTuesday is Today! Join the movement and support #SVM by donating to this amazing cause -> https://t.co/i2pO5MxMvl https://t.co/NMC1lDdp9d @EstherSHKimMD @adityasharmamd @GBarnesMD @RKolluriMD @Angiologist @herbaronowMD @stanhenkin
0
73
11
@mmonrealriete
manuel monreal
2 years
Patients with brain cancer have a much higher risk for intracranial bleeding during anticoagulation for VTE Find it here: https://t.co/CPfPnkLVLV
2
72
37
@Angiologist
Ido Weinberg, MD
2 years
"How do I manage anticoagulation around my procedure?" is one of the more common questions we get asked. So I put together this short explainer: https://t.co/RiDwEchG2E @mmonrealriete @adityasharmamd @GParmar_MD @stanhenkin @VladLakhter @AnticoagForum
0
73
26
@mmonrealriete
manuel monreal
2 years
20 years ago, cancer patients with VTE had similar rates of 30-day recurrence or major bleeding during anticoagulation Nowadays, major bleeds are 2-fold more common than VTE recurrences Safety is the issue
@LaurentBertole1
Laurent Bertoletti
2 years
Since 20 years, both management of #cancer and of venous thromboembolism #VTE improved drastically. Does it translate in the evolution of cancer-associated thrombosis? #CAT Happy to share the #RIETE experience, on more than 17 000 pts managed between 2001 and 2020 [thread⤵️]
0
59
36
@SVM_tweets
Society for Vascular Medicine | SVM
2 years
EKOS vs Flowtriever thrombectomy is not always a straightforward decision. Risk of bleeding 🩸 is REAL for both groups although no difference in 30-day readmission, in-hospital death, or ischemic strokes. https://t.co/hGcRMYpRHn #VascMedJC #SVM @VMJ_SVM @VladLakhter
0
68
24
@mmonrealriete
manuel monreal
2 years
Among 244 VTE patients with severe renal failure receiving enoxaparin for 6 months, VTE recurrences were less common than major bleeding: 4.1 vs. 13% But during the first 10 days, fatal PE was 5-fold more common than fatal bleeding: 2.1 vs. 0.4% Here: https://t.co/GU22F8VAo9
1
75
39
@Angiologist
Ido Weinberg, MD
2 years
Peripheral artery disease (PAD), common and serious, doesn't receive enough attention. Many people suffer leg symptoms with walking, but never receive appropriate care. I made this video to help #patients understand what to do: https://t.co/U1402qVCJG @GParmar_MD @MGHVascular
0
72
18
@VMJ_SVM
VascularMedicine
2 years
1
76
27
@Angiologist
Ido Weinberg, MD
2 years
Vascular Medicine 101: @OriSwed visits us from @TexasTech and speaks on "How pandemics change healthcare [forever?]". Cross disciplinary and thought provoking. @MGHHeartHealth @MGHVascular @GParmar_MD @sthomas013s
0
72
20
@PenVascular
Penumbra Vascular
2 years
Positive interim results from #STRIKEPE set the stage for additional clinical evidence for #CAVT with future #STORMPE results #ClotChat #WorldThrombosisDay @BrentKeeling @FMaeWestMD @drandrewsharp @RosovskyRachel @roblookstein @Angiologist @rchannick @JonnyMoriarty @sahilparikhmd
@penumbrainc
Penumbra, Inc.
2 years
@EverydayHealth A5. US HCPs: Early treatment for thrombosis is crucial, emphasized in our STRIKE-PE interim results at PERT 2023. Patients receiving interventional treatment showed notable improvements. #CAVT #ClotChat Rx only. For risk info: https://t.co/yoJC7MXLNo Clinical results may vary.
0
65
34